Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 16, 2021 21:25 UTC |
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 4,391 | $51.44 | $225,873.04 |
DisclosureSEC source: 0000721371-21-000144 · wf-form4_163709774270956.xml · nonDerivative · entry 1 CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,965 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 8,676 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:21 UTC |
Killefer NancyDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000142 · wf-form4_163698246095501.xml · nonDerivative · entry 1 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,554 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:19 UTC |
KENNY GREGORY BDirector
|
GrantCommon Shares | 6,215 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000140 · wf-form4_163698234070173.xml · nonDerivative · entry 1 KENNY GREGORY B · CIK 0001179497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,620 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:13 UTC |
JOHRI AKHILDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000136 · wf-form4_163698202555562.xml · nonDerivative · entry 1 JOHRI AKHIL · CIK 0001517450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,798 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:16 UTC |
SCARBOROUGH DEAN ADirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000138 · wf-form4_163698214859689.xml · nonDerivative · entry 1 SCARBOROUGH DEAN A · CIK 0001197584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,138 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:11 UTC |
DOWNEY BRUCEDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000134 · wf-form4_163698188805846.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,621 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:09 UTC |
COX CARRIE SMITHDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000132 · wf-form4_163698174117116.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,323 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:06 UTC |
Hall Patricia HemingwayDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000130 · wf-form4_163698158810174.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:04 UTC |
WEILAND JOHN HDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000128 · wf-form4_163698143910876.xml · nonDerivative · entry 1 WEILAND JOHN H · CIK 0001204663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,138 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:00 UTC |
Evans David CDirector
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000126 · wf-form4_163698123789506.xml · nonDerivative · entry 1 Evans David C · CIK 0001375909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 12:58 UTC |
Edison Sheri H.Director
|
GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000124 · wf-form4_163698110793285.xml · nonDerivative · entry 1 Edison Sheri H. · CIK 0001413612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:03 UTC |
SCARBOROUGH DEAN ADirector
|
GrantPhantom Stock · Derivative | 592 | $48.54 | $28,735.68 |
DisclosureSEC source: 0000721371-21-000104 · wf-form4_163459098270139.xml · derivative · entry 1 SCARBOROUGH DEAN A · CIK 0001197584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,594 Underlying: Common Shares · 592 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:02 UTC |
LOSH J MICHAELDirector
|
GrantPhantom Stock · Derivative | 592 | $48.54 | $28,735.68 |
DisclosureSEC source: 0000721371-21-000103 · wf-form4_163459091177988.xml · derivative · entry 1 LOSH J MICHAEL · CIK 0001199190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,264 Underlying: Common Shares · 592 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 21:00 UTC |
Snow Ola MChief Human Resources Officer
|
Tax withholdingCommon Shares | 726 | $48.63 | $35,305.38 |
DisclosureSEC source: 0000721371-21-000102 · wf-form4_163459082234219.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,969 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,618 RSUs. F2 · price: Reflects closing price on prior business day. Read SEC document |
| October 15, 2021 Filed Aug 8, 2023 23:48 UTC |
Snow Ola MChief Human Resources Officer
|
PurchaseCommon Shares | 212 | $48.88 | $10,362.56 |
DisclosureSEC source: 0000721371-23-000054 · wf-form4_169153847319351.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,173 F1 · kind: Reflects an inadvertent purchase of shares pursuant to an automatic broker-administered dividend reinvestment program. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 21:05 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
Tax withholdingCommon Shares | 7,739 | $51.70 | $400,106.30 |
DisclosureSEC source: 0000721371-21-000098 · wf-form4_162923428015068.xml · nonDerivative · entry 2 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,892 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 7,915 RSUs and 9,337 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 21:05 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
GrantCommon Shares | 8,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000098 · wf-form4_162923428015068.xml · nonDerivative · entry 1 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,631 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:59 UTC |
Mason Stephen MCEO, Medical Segment
|
Tax withholdingCommon Shares | 10,395 | $51.70 | $537,421.50 |
DisclosureSEC source: 0000721371-21-000096 · wf-form4_162923395082308.xml · nonDerivative · entry 2 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,888 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 15,964 RSUs and 7,209 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:59 UTC |
Mason Stephen MCEO, Medical Segment
|
GrantCommon Shares | 21,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000096 · wf-form4_162923395082308.xml · nonDerivative · entry 1 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,283 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:54 UTC |
Snow Ola MChief Human Resources Officer
|
Tax withholdingCommon Shares | 5,663 | $51.70 | $292,777.10 |
DisclosureSEC source: 0000721371-21-000094 · wf-form4_162923366036308.xml · nonDerivative · entry 2 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,695 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 9,285 RSUs and 2,929 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:54 UTC |
Snow Ola MChief Human Resources Officer
|
GrantCommon Shares | 13,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000094 · wf-form4_162923366036308.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,358 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:49 UTC |
English Patricia MChief Accounting Officer
|
Tax withholdingCommon Shares | 817 | $51.70 | $42,238.90 |
DisclosureSEC source: 0000721371-21-000092 · wf-form4_162923333021610.xml · nonDerivative · entry 2 English Patricia M · CIK 0001823407 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,169 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,759 RSUs. F3 · price: Reflects closing price on transaction date. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:49 UTC |
English Patricia MChief Accounting Officer
|
GrantCommon Shares | 2,901 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000092 · wf-form4_162923333021610.xml · nonDerivative · entry 1 English Patricia M · CIK 0001823407 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,986 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:41 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 13,884 | $51.70 | $717,802.80 |
DisclosureSEC source: 0000721371-21-000090 · wf-form4_162923286764717.xml · nonDerivative · entry 2 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,814 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 12,763 RSUs and 18,190 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:41 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
GrantCommon Shares | 19,342 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000090 · wf-form4_162923286764717.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,698 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:35 UTC |
Rice Brian SChief Information Officer
|
Tax withholdingCommon Shares | 6,362 | $51.70 | $328,915.40 |
DisclosureSEC source: 0000721371-21-000088 · wf-form4_162923249174735.xml · nonDerivative · entry 2 Rice Brian S · CIK 0001767478 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,374 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,659 RSUs and 8,291 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:35 UTC |
Rice Brian SChief Information Officer
|
GrantCommon Shares | 8,511 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000088 · wf-form4_162923249174735.xml · nonDerivative · entry 1 Rice Brian S · CIK 0001767478 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,736 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:29 UTC |
Hollar Jason M.Chief Financial Officer
|
Tax withholdingCommon Shares | 2,785 | $51.70 | $143,984.50 |
DisclosureSEC source: 0000721371-21-000086 · wf-form4_162923213898600.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,517 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,209 RSUs. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:29 UTC |
Hollar Jason M.Chief Financial Officer
|
GrantCommon Shares | 21,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000086 · wf-form4_162923213898600.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,302 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:23 UTC |
Kaufmann Michael CDirector · CEO
|
Tax withholdingCommon Shares | 77,365 | $51.70 | $3,999,770.50 |
DisclosureSEC source: 0000721371-21-000084 · wf-form4_162923178622228.xml · nonDerivative · entry 2 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,452 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 77,525 RSUs and 98,866 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:23 UTC |
Kaufmann Michael CDirector · CEO
|
GrantCommon Shares | 85,106 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000084 · wf-form4_162923178622228.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 629,817 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:18 UTC |
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 19,991 | $51.70 | $1,033,534.70 |
DisclosureSEC source: 0000721371-21-000082 · wf-form4_162923148179757.xml · nonDerivative · entry 2 CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,356 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 15,560 RSUs and 23,946 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2021 Filed Aug 17, 2021 20:18 UTC |
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
|
GrantCommon Shares | 21,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000082 · wf-form4_162923148179757.xml · nonDerivative · entry 1 CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,347 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2022. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 11:32 UTC |
Kaufmann Michael CDirector · CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 76,909 | $0.00 Strike: $41.60 | $0.00 |
DisclosureSEC source: 0000721371-21-000077 · wf-form4_162885431435231.xml · derivative · entry 4 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 76,909 shares Expires 2021-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested in three equal annual installments beginning on August 15, 2012. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 11:32 UTC |
Kaufmann Michael CDirector · CEO
|
Tax withholdingCommon Shares | 68,631 | $51.69 | $3,547,536.39 |
DisclosureSEC source: 0000721371-21-000077 · wf-form4_162885431435231.xml · nonDerivative · entry 2 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,711 F1 · kind: No shares were sold in this transaction. Reflects surrender of shares to satisfy the exercise price and tax withholding obligations due upon exercise of a stock option that was to expire on August 15, 2021. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 11:32 UTC |
Kaufmann Michael CDirector · CEO
|
Exercise / conversionCommon Shares | 76,909 | $41.60 | $3,199,414.40 |
DisclosureSEC source: 0000721371-21-000077 · wf-form4_162885431435231.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:45 UTC |
Rice Brian SChief Information Officer
|
GrantCommon Shares | 8,291 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000074 · wf-form4_162819625845445.xml · nonDerivative · entry 1 Rice Brian S · CIK 0001767478 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,225 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:42 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
GrantCommon Shares | 18,190 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000073 · wf-form4_162819608729949.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,356 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:37 UTC |
Mason Stephen MCEO, Medical Segment
|
GrantCommon Shares | 7,209 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000071 · wf-form4_162819573343481.xml · nonDerivative · entry 1 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,006 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:32 UTC |
CRAWFORD VICTOR L.CEO, Pharmaceutical Segment
|
GrantCommon Shares | 23,946 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000070 · wf-form4_162819542632603.xml · nonDerivative · entry 1 CRAWFORD VICTOR L. · CIK 0001449780 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,070 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:29 UTC |
Snow Ola MChief Human Resources Officer
|
GrantCommon Shares | 2,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000069 · wf-form4_162819532846345.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,818 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:28 UTC |
Kaufmann Michael CDirector · CEO
|
GrantCommon Shares | 98,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000068 · wf-form4_162819523961654.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,433 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:26 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
GrantCommon Shares | 9,337 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000067 · wf-form4_162819497901687.xml · nonDerivative · entry 1 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,120 F1 · kind: Reflects performance share units that will settle on August 15, 2021. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 20:23 UTC |
LOSH J MICHAELDirector
|
GrantPhantom Stock · Derivative | 506 | $56.77 | $28,725.62 |
DisclosureSEC source: 0000721371-21-000056 · wf-form4_162681256721678.xml · derivative · entry 1 LOSH J MICHAEL · CIK 0001199190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567 Underlying: Common Shares · 506 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 20:21 UTC |
SCARBOROUGH DEAN ADirector
|
GrantPhantom Stock · Derivative | 506 | $56.77 | $28,725.62 |
DisclosureSEC source: 0000721371-21-000055 · wf-form4_162681247327675.xml · derivative · entry 1 SCARBOROUGH DEAN A · CIK 0001197584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,941 Underlying: Common Shares · 506 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 11:37 UTC |
Kaufmann Michael CDirector · CEO
|
Tax withholdingCommon Shares | 6,962 | $57.28 | $398,783.36 |
DisclosureSEC source: 0000721371-21-000050 · wf-form4_162496661631605.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,567 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 21,231 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| May 15, 2021 Filed May 18, 2021 11:58 UTC |
Hollar Jason M.Chief Financial Officer
|
Tax withholdingCommon Shares | 2,033 | $56.34 | $114,539.22 |
DisclosureSEC source: 0000721371-21-000043 · wf-form4_162133906614970.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,025 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,809 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 11:20 UTC |
LOSH J MICHAELDirector
|
GrantPhantom Stock · Derivative | 472 | $60.82 | $28,707.04 |
DisclosureSEC source: 0000721371-21-000035 · wf-form4_161857203091965.xml · derivative · entry 1 LOSH J MICHAEL · CIK 0001199190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,966 Underlying: Common Shares · 472 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 11:18 UTC |
SCARBOROUGH DEAN ADirector
|
GrantPhantom Stock · Derivative | 472 | $60.82 | $28,707.04 |
DisclosureSEC source: 0000721371-21-000033 · wf-form4_161857190961490.xml · derivative · entry 1 SCARBOROUGH DEAN A · CIK 0001197584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,381 Underlying: Common Shares · 472 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 21:03 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 911 | $57.35 | $52,245.85 |
DisclosureSEC source: 0000721371-21-000023 · wf-form4_161592860063642.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,705 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 2,984 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.